Value-Based Contracting in ABA: Who’s Doing It and What the Early Data Shows

NEW YORK — At the Autism Investor Summit East in November 2025, the question was no longer whether the ABA industry would move toward value-based contracting. It was whether it could. The payers in the room wanted outcomes data. The providers in the room wanted higher rates. And the gap between those two positions — measured in the absence of standardized metrics, the fragmentation of data systems, and the sheer operational difficulty of tying reimbursement to clinical progress in a therapy that can span years — was wider than the conference panels suggested.

The fundamental economics are clear. ABA therapy volume increased 267% from 2019 to 2024. Medicaid-covered services grew 298% in that period; commercial services grew 249%. The U.S. ABA market was valued at approximately $7.97 billion in 2025 and is projected to reach $9.96 billion by 2030. Virtually all of that revenue flows through fee-for-service contracts that reimburse providers for hours delivered, regardless of whether those hours produce measurable improvement in the patient’s functioning. The incentive structure is, in the blunt language of a Trilliant Health report published in December 2025, “perverse.”

“The current payment structure, which reimburses based on service volume rather than outcomes, creates misaligned incentives,” the Trilliant Health analysis stated. “Providers benefit financially from maximizing billable hours regardless of whether treatment produces meaningful improvements in children’s functioning.” The report recommended tying reimbursement to care outcomes — but acknowledged that no infrastructure currently exists to do so at scale.

The Metrics Problem: Nine Measures Nobody Agrees On

The prerequisite for value-based contracting is a set of standardized outcome measures that both payers and providers accept. In ABA, that prerequisite does not yet exist. The field has dozens of assessment instruments — the VB-MAPP, ABLLS-R, Vineland-3, PDDBI, SRS-2, and many others — but no consensus on which instruments should serve as the basis for measuring treatment value across providers and payer contracts.

The Behavioral Health Center of Excellence attempted to solve this in 2021 with the BHCOE ABA Outcomes Framework, a research-based structure for selecting assessment tools that could enable cross-patient and cross-provider comparison. BHCOE’s National Autism Data Registry, launched in 2023, brought together founding members including Hopebridge, Acorn Health, Center for Social Dynamics, Proud Moments, JumpStart Autism Center, and Ascend Behavior Partners — organizations collectively representing over 6.2 million direct treatment hours, 16,000 patients across 24 states, and more than one million data points. The registry tracks nine quality measures for ABA services and supports outcome measurement across 13 assessment tools in four categories: autism severity, norm-referenced skills assessment, criterion-referenced skills assessment, and quality of life.

In late 2025, CASP acquired BHCOE, bringing the two major accreditation bodies under one organizational umbrella through the Autism Commission on Quality. The consolidation may accelerate metrics standardization — but the industry is still far from the nine agreed-upon measures that Lighthouse Autism Center president Barbara Gromacki described at AIS East as the minimum viable threshold for equitable value-based contracting.

Who’s Actually Doing It: The Three Models in the Market

Despite the metrics gap, a small number of payer-provider relationships have moved beyond discussion into operational value-based arrangements. None is a pure outcomes-based contract in the way the term is used in primary care or oncology. All are hybrid models that layer quality incentives or measurement requirements on top of a fee-for-service base. They represent the leading edge of what the industry is actually willing to put into a contract.

Model 1: Evernorth/BHCOE — The Quality Performance Framework. Evernorth, the health services division of Cigna, partnered with BHCOE in April 2022 to develop quality performance measures for ABA providers. The partnership was described as “first-of-its-kind” and focused on establishing foundational measures for ABA treatment, increasing transparency for patients about provider quality, and creating incentive structures for providers to deliver measurable outcomes. Evernorth’s broader behavioral health strategy includes over 40,000 clinicians on value-based care arrangements as of early 2024, and its Evernorth Behavioral Care Group, launched in March 2024, explicitly centers value-based and measurement-based care. The ABA-specific framework uses BHCOE’s outcome measures and accreditation data to create a quality tier that informs contracting. It is not a pure outcomes-based reimbursement model, but it represents the most developed commercial payer framework tying ABA quality data to network status and incentive payments.

Model 2: The NADR Benchmarking Approach — Provider-Led Data Infrastructure. BHCOE’s National Autism Data Registry provides the data infrastructure that multiple payers and providers are using to benchmark quality and build toward value-based arrangements. The registry’s founding members — Hopebridge, Acorn Health, Center for Social Dynamics, Proud Moments, JumpStart, and Ascend — collectively contribute longitudinal data on process, structure, outcome, and cost measures. The NADR does not itself constitute a value-based contract, but it provides the measurement platform that payers require before they will agree to one. Multiple payer conversations are reportedly using NADR benchmarks as the evidentiary basis for quality incentive structures that sit atop standard fee-for-service rates.

Model 3: The Massachusetts Accreditation Mandate — State-Enforced Quality as a Proxy. Massachusetts implemented an accreditation mandate in 2025 requiring MassHealth MCOs to contract only with ABA providers holding BHCOE, CASP/ACQ, or equivalent accreditation. This is not a value-based contract in the traditional sense, but it functions as a state-level quality gate that removes non-accredited providers from the Medicaid network. The approach uses credentialing as a cost-control mechanism: rather than cutting rates or capping hours, the state requires providers to demonstrate organizational quality standards as a condition of participation. The model is being closely watched by other states facing ABA spending crises as an alternative to blunt rate reductions.

What Payers Are Saying — and What They’re Not Saying

The payer messaging on value-based care in ABA has become increasingly explicit. OptumHealth Behavioral Health Solutions CEO Trip Hofer said at the BHB VALUE conference: “If you want a higher rate, I need data. I need to see what you are doing.” He added that five years ago, providers could have secured rate increases by being vocal. Now, rate decisions are driven by demonstrated outcomes.

Aetna deputy chief psychiatric officer Deborah Fernandez-Turner acknowledged the measurement challenge: the lack of a clear quantitative biomarker for behavioral health progress — the equivalent of a hemoglobin A1C for depression — makes outcomes-based contracting structurally harder in ABA than in chronic disease management. The assessment instruments available are subjective, based on caregiver and clinician reporting, and vary in what they measure and how they measure it.

What payers are not saying publicly — but what the M&A advisory community is saying explicitly — is that value-based contracting in ABA is also a cost containment strategy. Brentwood Capital Advisors managing director Dan Beuerlein told AIS East that he does not expect major payers or benefit managers to acquire ABA practices, but he does expect evolution toward value-based arrangements. For investors evaluating acquisition targets, quality and outcomes tracking are now due diligence requirements, not aspirational features. Morgan Health partner Dan Hartman noted that combined ABA and multi-specialty care produces better outcomes in the data — which suggests that the next generation of value-based contracts may favor integrated providers over standalone ABA organizations.

The 267% Problem: Why Volume Growth Forces the Issue

The urgency behind value-based contracting in ABA is driven by the same spending growth that is producing Medicaid rate cuts, federal audits, and payer audit programs across the industry. ABA claims volume increased 267% from 2019 to 2024. Medicaid ABA spending in Indiana grew from $14 million to $611 million in six years. North Carolina’s projected spending growth is 423%. Individual ABA therapy, delivered by RBTs under BCBA supervision, accounts for 85% of all measured claims.

This volume growth, combined with the absence of standardized outcome tracking, creates a legitimacy problem for the industry. Without data demonstrating that the spending produces measurable improvement, payers and legislators default to the tools they have: rate cuts, hour caps, prior authorization requirements, and retroactive audits. Value-based contracting is, in this framing, not a payer concession to provider demands for higher rates. It is the industry’s best available argument against blunt cost reduction.

The Trilliant Health report stated the case directly: “Without systematic tracking of diagnostic processes or treatment outcomes, states lack the data necessary to determine whether spending increases reflect appropriate expansion of services or systemic problems with overdiagnosis and unnecessary treatment.” Value-based contracting, if it works, provides that data. If it doesn’t work — or if it doesn’t arrive fast enough — the alternative is the rate-cutting and audit environment that is already reshaping the industry.

What Providers Should Be Doing Now

Invest in outcomes measurement infrastructure. If your practice is not systematically collecting standardized outcome data — using validated instruments administered at consistent intervals, with data stored in a format that can be aggregated and reported — you are not ready for any value-based arrangement. Start with the BHCOE ABA Outcomes Framework as a reference point. Implement at least one norm-referenced and one criterion-referenced assessment tool across your patient population.

Pursue accreditation. ACQ, BHCOE (now under CASP), and equivalent accreditation programs are becoming prerequisites for payer network participation, not differentiators. Massachusetts has already mandated it. Other states are watching. Accreditation signals to payers that your organization meets quality standards that can support value-based contracting.

Participate in data registries. The NADR and similar platforms provide the benchmarking data that payers use to evaluate whether a provider’s outcomes justify higher rates or preferred status. Providers who contribute data to these registries position themselves as value-based-ready. Providers who do not are invisible to the payers making contracting decisions.

Build multi-specialty capabilities. The data showing that combined ABA, speech, and occupational therapy produces better outcomes than ABA alone is reshaping payer expectations. Providers who can offer integrated care are better positioned for value-based contracts that reward comprehensive outcomes rather than single-service utilization.

The Long View

The ABA industry’s transition from fee-for-service to value-based care will not happen in a single contracting cycle. It will happen incrementally, through quality incentive layers on top of FFS bases, through accreditation mandates that function as quality gates, through data registries that create the benchmarks payers need, and through the slow accumulation of evidence that the outcomes justify the investment.

The risk is that the transition happens too slowly. Every quarter that the industry bills $2 billion in FFS claims without standardized outcome data is a quarter in which payers, legislators, and auditors have more ammunition to argue that the spending is not producing commensurate value. The providers and payers who are building the measurement infrastructure now — the Evernorth/BHCOE frameworks, the NADR registries, the Massachusetts accreditation mandates — are constructing the floor on which the entire industry will eventually stand.

The ones who are not building it are standing on fee-for-service ground that is eroding beneath them. The rate cuts are coming. The audits are coming. The hour caps are coming. The only durable defense is a body of evidence demonstrating that the therapy works, measured in terms that payers accept, reported in formats they can use, and tied to contracts that reward quality over volume. That infrastructure does not yet exist at scale. Building it is the defining operational challenge of the next three years.

AT A GLANCE

Sources & References

1.  Behavioral Health Business. “Autism Care Faces Market Reckoning as Payers, Investors Push for Proof of Outcomes.” November 21, 2025

2.  Behavioral Health Business. “ABA Volume Skyrocketed by 267% from 2019 to 2024.” December 22, 2025 (Trilliant Health analysis)

3.  Behavioral Health Business. “7 Autism Therapy Companies to Watch in 2025.” July 2025

4.  Behavioral Health Business. “Optum, Aetna and UHS Leaders Offer Outcomes Roadmap for Value-Based Contracting.” March 2023

5.  Behavioral Health Business. “Why the Payvider Model Is Growing in Behavioral Health.” November 26, 2025

6.  Behavioral Health Business. “Evernorth Establishes Behavioral Health Group, Emphasizing Value-Based Approach.” March 2024

7.  BHCOE. “Evernorth and BHCOE Announce Partnership.” April 14, 2022

8.  BHCOE. “BHCOE Gives Autism Field a Needed Boost in Measuring Treatment Outcomes.” September 2021

9.  BHCOE. “National Autism Data Registry Launch.” November 2023

10.  CASP. “CASP Has Acquired Jade Health, Including BHCOE.” Late 2025

11.  Autism Commission on Quality (ACQ). About and FAQ. autismcommission.org (accessed March 2026)

12.  ABA Matrix. “ABA Trends 2026: Forces Set to Shape the Field.” December 2025

13.  Raven Health. “6 Game-Changing ABA Trends in 2025.” October 2025

14.  Autism Spectrum News. “The Future of Autism and ABA: Predicting Outcomes.” September 2023